Research Ethics

The centre for Applied Ethics was created in April 2014 as part of a broad restructuring of ethics services at the MUHC.  The 9 Research Ethics Boards (REBs), as well as research ethics, support services have been part of this exercise.   Changes to the REB structure come into effect April 1, 2015.  These will not affect the general principles of how research involving humans is approved.  However, these changes aim at increasing efficiency while maintaining high-quality review of research.

  • There is one MUHC REB and 5 specialised panels
  • The 5 specialised panels will conduct both Science and Ethics review and will meet twice a month on average;
  • Submission deadlines are abolished;
  • The CAE staff will conduct pre-reviews of all studies to ensure 
    • completeness, 
    • minimal quality of documents submitted and 
    • assess level of risk and initiate delegated review of minimal risk studies (instead of full board reviews).

The MUHC currently has a single REB with 5 specialized panels :

  • PED
  • CT1 (Oncology)
  • CT2
  • CTGQ

5 Panels of the MUHC-REB

Pediatrics (PED):
  • All projects involving minors
Clinical Trials 1 (CT1):
  • Oncology
  • Radiation-oncology
  • ObGyn
  • Urology
  • Palliative care research associated to oncology
Cells, tissues, genetics & qualitative research (CTGQ):
  • Artificial intelligence (AI)
  • Genetics
  • Biobanking and registries
  • Research on cells and tissues
  • Experimental  cell therapies
  • Pathology
  • Regenerative medicine
  • Epidemiology 
  • Qualitative research
  • Fundamental research
Neurosciences-Psychiatry (NEUPSY):
All projects in:
  • Neuroscience
  • Psychiatry
  • Psychology
Clinical Trials 2 (CT2):
  • Surgery
  • Cardiology
  • Orthopaedics
  • Endocrinology
  • Anesthesiology
  • Gastroenterology
  • Urology
  • Devices
  • Infectious diseases
  • Chronic illness
  • Respiratory and
  • Transplant

MUHC REB Chair:  Marie Hirtle

Person formally mandated at the MUHC to authorize projects: Annie Duguay



REB Coordination 


Dr. Carlo Cicero

Ms. Elizabeth Craven


Dr. Serge Gauthier, Mr. Renaud Boulanger

Ms. Joanne Lebrasseur


Mr. Vincent Lajoie

Ms. Elizabeth Craven


Dr. Bertrand Lebouché, Ms. Sonya Page, Ms. Franca Cantini, Me Brigitte Paquet

Ms. Sonia Cantini


Me Marie Hirtle Mr. James Ellasus

Schedule of REB FULLBOARD meetings

For the schedule of REB full board meetings, please see calendar page on Nagano. Note that studies that are more than minimal risk are reviewed at the fullboard.

Please enter your study in Nagano as soon as possible to initiate the review process.

Updated June 16 2023